|
|
|
BC |
supplementation |
|
placebo |
|
|
|
|
|
Baseline |
4 months |
d |
Baseline |
4 months |
d |
| T-score LS |
Normal |
0.5 ± 1.3 |
0.5 ± 1.1 |
0.01 |
−0.5 ± 0.6 |
−0.4 ± 0.7 |
0.16 |
|
|
Osteopenia |
−1.4 ± 0.7 |
−1.5 ± 0.6 |
0.15 |
−1.4 ± 0.7 |
−1.1 ± 0.8a |
0.40 |
|
|
Osteporosis |
−1.9 ± 0.9 |
−1.8 ± 0.8 |
0.16 |
−2.1 ± 0.7 |
−2.1 ± 0.6 |
0.03 |
| T-score FN |
Normal |
−0.3 ± 0.9 |
−0.4 ± 1.0 |
0.03 |
−0.4 ± 0.7 |
−0.4 ± 0.7 |
0.00 |
|
|
Osteopenia |
−1.0 ± 0.9 |
−1.1 ± 0.8 |
0.16 |
−0.8 ± 0.9 |
−0.7 ± 0.9 |
0.09 |
|
|
Osteporosis |
−1.7 ± 0.7 |
−1.8 ± 0.9 |
0.13 |
−1.5 ± 0.7 |
−1.5 ± 0.5 |
0.04 |
| T-score Arm |
Normal |
−0.2 ± 0.6 |
−0.2 ± 0.7 |
0.00 |
−0.1 ± 0.7 |
−0.3 ± 0.6 |
0.23 |
|
|
Osteopenia |
−1.1 ± 0.6 |
−1.0 ± 0.6 |
0.17 |
−0.9 ± 0.7 |
−1.0 ± 1.1 |
0.12 |
|
|
Osteporosis |
−1.7 ± 1.9 |
−1.4 ± 1.4 |
0.14 |
−1.9 ± 3.1 |
−2.5 ± 0.7 |
0.24 |